Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2018 Filed Mar 7, 2018 00:40 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 429 | $101.00 | $43,329.00 |
DisclosureSEC source: 0001022079-18-000089 · wf-form4_152038322826620.xml · nonDerivative · entry 2 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,803 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share awards. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:40 UTC |
Klug Robert AVP, Corporate Controller
|
GrantCommon Stock | 1,365 | $101.00 | $137,865.00 |
DisclosureSEC source: 0001022079-18-000089 · wf-form4_152038322826620.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,206 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of performance share awards dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:39 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 6,764 | $101.00 | $683,164.00 |
DisclosureSEC source: 0001022079-18-000088 · wf-form4_152038317924738.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,189 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:39 UTC |
Davis J. E.EVP, General Diagnostics
|
GrantCommon Stock | 11,886 | $101.00 | $1,200,486.00 |
DisclosureSEC source: 0001022079-18-000088 · wf-form4_152038317924738.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,909 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:38 UTC |
Cunningham EverettSVP, Commercial
|
Disposition to issuerCommon Stock | 5,393 | $101.00 | $544,693.00 |
DisclosureSEC source: 0001022079-18-000087 · wf-form4_152038309986714.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,916 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:38 UTC |
Cunningham EverettSVP, Commercial
|
GrantCommon Stock | 10,949 | $101.00 | $1,105,849.00 |
DisclosureSEC source: 0001022079-18-000087 · wf-form4_152038309986714.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,266 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:37 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
Tax withholdingCommon Stock | 5,393 | $101.00 | $544,693.00 |
DisclosureSEC source: 0001022079-18-000086 · wf-form4_152038303505837.xml · nonDerivative · entry 2 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,498 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:37 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
GrantCommon Stock | 10,949 | $101.00 | $1,105,849.00 |
DisclosureSEC source: 0001022079-18-000086 · wf-form4_152038303505837.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,891 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23, 2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:36 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 5,393 | $101.00 | $544,693.00 |
DisclosureSEC source: 0001022079-18-000085 · wf-form4_152038297008615.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,497 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 02, 2018 Filed Mar 7, 2018 00:36 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 10,949 | $101.00 | $1,105,849.00 |
DisclosureSEC source: 0001022079-18-000085 · wf-form4_152038297008615.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,890 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 23,2015, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 01, 2018 Filed Mar 25, 2019 20:36 UTC |
Cunningham EverettSVP, Commercial
|
GiftCommon Stock | 491 | $104.78 | $51,444.53 |
DisclosureSEC source: 0001022079-19-000096 · wf-form4_155354617623001.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,760 F1 · kind: This late reporting of a charitable gift is due to an inadvertent administrative error. F2 · balance_after: This total reflects the current amount of securities beneficially owned by the reporting person as of the filing date of this Form 4. For Form 4s filed by this reporting person since March 1, 2018, this column erroneously included the 491 shares reported herein as a charitable gift. In the Form 4 filed on March 4, 2019, this column also erroneously included 60 shares due to over-reporting of exempt purchases made by the reporting person under the Company's stock purchase plan. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 22:08 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 496 | $104.99 | $52,075.04 |
DisclosureSEC source: 0001022079-18-000070 · wf-form4_151994208816390.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,766 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 29, 2016. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:58 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 572 | $104.99 | $60,054.28 |
DisclosureSEC source: 0001022079-18-000064 · wf-form4_151994150641810.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,941 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:56 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 648 | $104.99 | $68,033.52 |
DisclosureSEC source: 0001022079-18-000062 · wf-form4_151994136827237.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,023 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:11 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 3,017 | $101.43 | $306,014.31 |
DisclosureSEC source: 0001022079-18-000072 · wf-form4_151994226136351.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,708 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:08 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 927 | $104.10 | $96,500.70 |
DisclosureSEC source: 0001022079-18-000070 · wf-form4_151994208816390.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,262 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 29, 2016. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:08 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 482 | $101.43 | $48,889.26 |
DisclosureSEC source: 0001022079-18-000070 · wf-form4_151994208816390.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,189 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:05 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 62 | $101.43 | $6,288.66 |
DisclosureSEC source: 0001022079-18-000068 · wf-form4_151994193010567.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,841 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 22:03 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 585 | $101.43 | $59,336.55 |
DisclosureSEC source: 0001022079-18-000066 · wf-form4_151994174862559.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,090 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:58 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 1,248 | $104.10 | $129,916.80 |
DisclosureSEC source: 0001022079-18-000064 · wf-form4_151994150641810.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,513 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:58 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 556 | $101.43 | $56,395.08 |
DisclosureSEC source: 0001022079-18-000064 · wf-form4_151994150641810.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,761 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:56 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 1,150 | $104.10 | $119,715.00 |
DisclosureSEC source: 0001022079-18-000062 · wf-form4_151994136827237.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,671 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:56 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 856 | $101.43 | $86,824.08 |
DisclosureSEC source: 0001022079-18-000062 · wf-form4_151994136827237.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,821 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:36 UTC |
Cunningham EverettSVP, Commercial
|
Tax withholdingCommon Stock | 556 | $101.43 | $56,395.08 |
DisclosureSEC source: 0001022079-18-000060 · wf-form4_151994016573443.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,317 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 27, 2018 Filed Mar 1, 2018 21:32 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
Tax withholdingCommon Stock | 556 | $101.43 | $56,395.08 |
DisclosureSEC source: 0001022079-18-000058 · wf-form4_151993988288847.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,942 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 27, 2018 Filed Mar 7, 2018 00:47 UTC Amendment |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 779 | $101.43 | $79,013.97 |
DisclosureSEC source: 0001022079-18-000093 · wf-form4a_152038364031486.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,534 F1 · date: This Amendment to the original Form 4 filed on March 1, 2018 is made solely to correct an administrative error with respect to the amount of shares reported to the issuer as having been disposed of, as reported on line 4 in Table 1 of the Form 4 as originally filed. F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:53 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 900 | $101.43 | $91,287.00 |
DisclosureSEC source: 0001022079-18-000056 · wf-form4_151976838822037.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,671 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:40 UTC |
Klug Robert AVP, Corporate Controller
|
SaleCommon Stock | 1,157 | $103.66 | $119,932.31 |
DisclosureSEC source: 0001022079-18-000054 · wf-form4_151976759949321.xml · nonDerivative · entry 3 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,903 F2 · shares: This transaction was executed in multiple trades at prices ranging from $103.65 to $103.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:40 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 77 | $101.43 | $7,810.11 |
DisclosureSEC source: 0001022079-18-000054 · wf-form4_151976759949321.xml · nonDerivative · entry 2 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,060 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:41 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 5,263 | $101.43 | $533,826.09 |
DisclosureSEC source: 0001022079-18-000055 · wf-form4_151976765840559.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,725 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:39 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 1,092 | $101.43 | $110,761.56 |
DisclosureSEC source: 0001022079-18-000053 · wf-form4_151976754246593.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,675 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:38 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 397 | $102.74 | $40,787.78 |
DisclosureSEC source: 0001022079-18-000052 · wf-form4_151976745800470.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,317 F2 · shares: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 27, 2017. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:38 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 1,212 | $101.43 | $122,933.16 |
DisclosureSEC source: 0001022079-18-000052 · wf-form4_151976745800470.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,714 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:37 UTC |
Davis J. E.EVP, General Diagnostics
|
SaleCommon Stock | 494 | $102.74 | $50,753.56 |
DisclosureSEC source: 0001022079-18-000051 · wf-form4_151976740021991.xml · nonDerivative · entry 3 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,677 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 28, 2017. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:37 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 1,520 | $101.43 | $154,173.60 |
DisclosureSEC source: 0001022079-18-000051 · wf-form4_151976740021991.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,171 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:35 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
Tax withholdingCommon Stock | 1,212 | $101.43 | $122,933.16 |
DisclosureSEC source: 0001022079-18-000050 · wf-form4_151976721013992.xml · nonDerivative · entry 2 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,498 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 21:35 UTC |
Cunningham EverettSVP, Commercial
|
Tax withholdingCommon Stock | 1,212 | $101.43 | $122,933.16 |
DisclosureSEC source: 0001022079-18-000049 · wf-form4_151976728775436.xml · nonDerivative · entry 2 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,873 Read SEC document |
| February 26, 2018 Filed Mar 7, 2018 00:45 UTC Amendment |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 1,454 | $101.43 | $147,479.22 |
DisclosureSEC source: 0001022079-18-000092 · wf-form4a_152038350470927.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,313 F2 · date: This Amendment to the original Form 4 filed on February 27, 2018 is made solely to correct an administrative error with respect to the amount of shares reported to the issuer as having been disposed of, as reported on line 4 in Table 1 of the Form 4 as originally filed. F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:53 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 317 | $102.69 | $32,552.73 |
DisclosureSEC source: 0001022079-18-000056 · wf-form4_151976838822037.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:40 UTC |
Klug Robert AVP, Corporate Controller
|
Tax withholdingCommon Stock | 43 | $102.69 | $4,415.67 |
DisclosureSEC source: 0001022079-18-000054 · wf-form4_151976759949321.xml · nonDerivative · entry 1 Klug Robert A · CIK 0001347843 · VP, Corporate Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,137 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:41 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 2,094 | $102.69 | $215,032.86 |
DisclosureSEC source: 0001022079-18-000055 · wf-form4_151976765840559.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,988 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:39 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 592 | $102.69 | $60,792.48 |
DisclosureSEC source: 0001022079-18-000053 · wf-form4_151976754246593.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,767 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:38 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 386 | $102.69 | $39,638.34 |
DisclosureSEC source: 0001022079-18-000052 · wf-form4_151976745800470.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,926 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:37 UTC |
Davis J. E.EVP, General Diagnostics
|
Tax withholdingCommon Stock | 654 | $102.69 | $67,159.26 |
DisclosureSEC source: 0001022079-18-000051 · wf-form4_151976740021991.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP, General Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,691 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:35 UTC |
Cohen Jon RSVP & Group Exec. Diag. Sol.
|
Tax withholdingCommon Stock | 387 | $102.69 | $39,741.03 |
DisclosureSEC source: 0001022079-18-000050 · wf-form4_151976721013992.xml · nonDerivative · entry 1 Cohen Jon R · CIK 0001477972 · SVP & Group Exec. Diag. Sol. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,710 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:35 UTC |
Cunningham EverettSVP, Commercial
|
Tax withholdingCommon Stock | 387 | $102.69 | $39,741.03 |
DisclosureSEC source: 0001022079-18-000049 · wf-form4_151976728775436.xml · nonDerivative · entry 1 Cunningham Everett · CIK 0001564777 · SVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,085 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 21:32 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
Tax withholdingCommon Stock | 387 | $102.69 | $39,741.03 |
DisclosureSEC source: 0001022079-18-000048 · wf-form4_151976712501787.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,274 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2018 Filed Mar 7, 2018 00:45 UTC Amendment |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 592 | $102.69 | $60,792.48 |
DisclosureSEC source: 0001022079-18-000092 · wf-form4a_152038350470927.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,767 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:39 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 50,764 | $0.00 Strike: $103.57 | $0.00 |
DisclosureSEC source: 0001022079-18-000032 · wf-form4_151925992641098.xml · derivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,764 Underlying: Common Stock · 50,764 shares Expires 2028-02-19 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:39 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantCommon Stock | 4,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000032 · wf-form4_151925992641098.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,359 F1 · shares: Represents an award of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.